Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 29 | 2018 | 955 | 2.080 |
Why?
|
| Magnetic Resonance Imaging | 32 | 2018 | 1195 | 1.810 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2017 | 245 | 1.100 |
Why?
|
| Auditory Perception | 7 | 2009 | 80 | 0.940 |
Why?
|
| Brain Mapping | 16 | 2018 | 182 | 0.900 |
Why?
|
| Somatosensory Cortex | 2 | 2017 | 25 | 0.900 |
Why?
|
| Nerve Net | 9 | 2018 | 116 | 0.810 |
Why?
|
| Exercise | 5 | 2018 | 556 | 0.750 |
Why?
|
| Beta vulgaris | 2 | 2017 | 11 | 0.710 |
Why?
|
| Cerebral Infarction | 4 | 2008 | 24 | 0.700 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 83 | 0.700 |
Why?
|
| Visual Perception | 6 | 2009 | 110 | 0.650 |
Why?
|
| Visual Cortex | 6 | 2009 | 33 | 0.580 |
Why?
|
| Cerebrovascular Circulation | 9 | 2011 | 90 | 0.570 |
Why?
|
| Weight Loss | 4 | 2018 | 405 | 0.530 |
Why?
|
| Auditory Cortex | 4 | 2009 | 22 | 0.510 |
Why?
|
| Humans | 60 | 2019 | 28457 | 0.490 |
Why?
|
| Obesity | 6 | 2018 | 1067 | 0.460 |
Why?
|
| Cerebral Cortex | 5 | 2009 | 141 | 0.440 |
Why?
|
| Adult | 34 | 2018 | 8519 | 0.420 |
Why?
|
| Male | 38 | 2018 | 17998 | 0.400 |
Why?
|
| Aging | 6 | 2015 | 894 | 0.390 |
Why?
|
| Female | 37 | 2018 | 18229 | 0.390 |
Why?
|
| Music | 2 | 2007 | 5 | 0.380 |
Why?
|
| Career Mobility | 2 | 2019 | 17 | 0.370 |
Why?
|
| Acoustic Stimulation | 12 | 2018 | 122 | 0.370 |
Why?
|
| Attention | 3 | 2009 | 81 | 0.360 |
Why?
|
| Prefrontal Cortex | 2 | 2013 | 70 | 0.360 |
Why?
|
| Radiology | 2 | 2019 | 36 | 0.360 |
Why?
|
| Aged | 24 | 2018 | 9561 | 0.360 |
Why?
|
| Perception | 2 | 2012 | 91 | 0.350 |
Why?
|
| Faculty, Medical | 2 | 2019 | 76 | 0.340 |
Why?
|
| Neural Inhibition | 1 | 2008 | 27 | 0.340 |
Why?
|
| Gyrus Cinguli | 2 | 2008 | 22 | 0.340 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2011 | 66 | 0.340 |
Why?
|
| Cognition | 4 | 2016 | 529 | 0.330 |
Why?
|
| Spin Labels | 5 | 2011 | 26 | 0.330 |
Why?
|
| Middle Aged | 26 | 2018 | 11103 | 0.320 |
Why?
|
| Auditory Pathways | 2 | 2006 | 9 | 0.320 |
Why?
|
| Image Enhancement | 3 | 2009 | 70 | 0.310 |
Why?
|
| Dyslexia | 2 | 2005 | 8 | 0.310 |
Why?
|
| Tomography, X-Ray | 1 | 2006 | 5 | 0.310 |
Why?
|
| Walking | 2 | 2017 | 168 | 0.290 |
Why?
|
| Overweight | 2 | 2018 | 256 | 0.280 |
Why?
|
| Caffeine | 4 | 2009 | 31 | 0.280 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2018 | 111 | 0.280 |
Why?
|
| Software | 3 | 2015 | 111 | 0.270 |
Why?
|
| Nitrates | 2 | 2017 | 25 | 0.270 |
Why?
|
| Reference Books, Medical | 1 | 2004 | 2 | 0.260 |
Why?
|
| Software Validation | 1 | 2004 | 3 | 0.260 |
Why?
|
| Nicotine | 2 | 2017 | 168 | 0.260 |
Why?
|
| Medical Informatics Applications | 1 | 2004 | 4 | 0.260 |
Why?
|
| Medical Illustration | 1 | 2004 | 7 | 0.260 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 24 | 0.260 |
Why?
|
| Echo-Planar Imaging | 2 | 2009 | 16 | 0.260 |
Why?
|
| Perfusion | 1 | 2004 | 64 | 0.260 |
Why?
|
| Frontal Lobe | 1 | 2004 | 46 | 0.250 |
Why?
|
| Photic Stimulation | 10 | 2009 | 156 | 0.250 |
Why?
|
| Pesticides | 2 | 2017 | 237 | 0.250 |
Why?
|
| Occupational Exposure | 2 | 2017 | 285 | 0.240 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 108 | 0.240 |
Why?
|
| Internet | 1 | 2004 | 165 | 0.240 |
Why?
|
| Reaction Time | 5 | 2006 | 120 | 0.240 |
Why?
|
| Resistance Training | 3 | 2018 | 68 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2004 | 868 | 0.220 |
Why?
|
| Parietal Lobe | 2 | 2013 | 15 | 0.220 |
Why?
|
| Education, Medical, Graduate | 2 | 2019 | 107 | 0.210 |
Why?
|
| Neural Pathways | 5 | 2017 | 98 | 0.210 |
Why?
|
| Oxygen | 5 | 2017 | 144 | 0.200 |
Why?
|
| Reproducibility of Results | 5 | 2009 | 706 | 0.190 |
Why?
|
| Double-Blind Method | 3 | 2017 | 519 | 0.180 |
Why?
|
| Mentors | 1 | 2019 | 31 | 0.180 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 40 | 0.180 |
Why?
|
| Memory, Short-Term | 2 | 2016 | 59 | 0.170 |
Why?
|
| Body Composition | 2 | 2017 | 358 | 0.170 |
Why?
|
| Dietary Supplements | 2 | 2017 | 170 | 0.170 |
Why?
|
| Pain | 2 | 2011 | 262 | 0.170 |
Why?
|
| Military Personnel | 1 | 2018 | 83 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2009 | 134 | 0.160 |
Why?
|
| Cerebrovascular Disorders | 2 | 2009 | 53 | 0.150 |
Why?
|
| Disability Evaluation | 1 | 2017 | 223 | 0.150 |
Why?
|
| Quality of Life | 3 | 2017 | 843 | 0.150 |
Why?
|
| Cerebellum | 2 | 2013 | 29 | 0.150 |
Why?
|
| Psychomotor Performance | 3 | 2005 | 97 | 0.150 |
Why?
|
| Central Nervous System Stimulants | 2 | 2009 | 70 | 0.150 |
Why?
|
| Nitrites | 2 | 2017 | 22 | 0.150 |
Why?
|
| Nonlinear Dynamics | 1 | 2014 | 52 | 0.130 |
Why?
|
| Gambling | 1 | 2014 | 6 | 0.130 |
Why?
|
| Functional Laterality | 3 | 2011 | 61 | 0.130 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 229 | 0.130 |
Why?
|
| Brain Injuries | 2 | 2011 | 90 | 0.130 |
Why?
|
| Emigrants and Immigrants | 1 | 2017 | 272 | 0.130 |
Why?
|
| Thalamus | 1 | 2013 | 42 | 0.130 |
Why?
|
| Analysis of Variance | 6 | 2011 | 472 | 0.120 |
Why?
|
| Choice Behavior | 1 | 2014 | 80 | 0.120 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 341 | 0.120 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 107 | 0.120 |
Why?
|
| Motor Activity | 1 | 2015 | 322 | 0.120 |
Why?
|
| Mobility Limitation | 1 | 2014 | 181 | 0.120 |
Why?
|
| Social Control, Informal | 1 | 2012 | 8 | 0.110 |
Why?
|
| Aged, 80 and over | 7 | 2016 | 3692 | 0.110 |
Why?
|
| Decision Making | 1 | 2014 | 173 | 0.110 |
Why?
|
| Appetite | 1 | 2012 | 18 | 0.110 |
Why?
|
| Food Preferences | 1 | 2012 | 38 | 0.110 |
Why?
|
| Hispanic Americans | 2 | 2017 | 1093 | 0.110 |
Why?
|
| Putamen | 1 | 2011 | 25 | 0.110 |
Why?
|
| Holistic Health | 1 | 2011 | 9 | 0.110 |
Why?
|
| Therapeutic Touch | 1 | 2011 | 10 | 0.110 |
Why?
|
| Diet | 2 | 2012 | 342 | 0.110 |
Why?
|
| Comprehension | 1 | 2011 | 19 | 0.110 |
Why?
|
| Young Adult | 6 | 2015 | 2372 | 0.110 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2011 | 18 | 0.110 |
Why?
|
| Heart Failure | 1 | 2017 | 611 | 0.100 |
Why?
|
| Cues | 3 | 2006 | 63 | 0.100 |
Why?
|
| Pruritus | 1 | 2011 | 60 | 0.100 |
Why?
|
| Neuropsychological Tests | 4 | 2015 | 390 | 0.100 |
Why?
|
| Diagnosis, Differential | 3 | 2008 | 463 | 0.100 |
Why?
|
| Hypertension | 1 | 2017 | 948 | 0.100 |
Why?
|
| Perfusion Imaging | 1 | 2009 | 7 | 0.100 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 30 | 0.090 |
Why?
|
| Database Management Systems | 1 | 2009 | 11 | 0.090 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 7 | 0.090 |
Why?
|
| Information Storage and Retrieval | 1 | 2009 | 26 | 0.090 |
Why?
|
| Brain Diseases | 1 | 2009 | 39 | 0.090 |
Why?
|
| Models, Neurological | 2 | 2014 | 115 | 0.090 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2008 | 9 | 0.090 |
Why?
|
| Regression Analysis | 3 | 2017 | 291 | 0.090 |
Why?
|
| Cerebral Arteries | 1 | 2008 | 18 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2017 | 2921 | 0.090 |
Why?
|
| Neurologic Examination | 2 | 2011 | 27 | 0.090 |
Why?
|
| Models, Biological | 1 | 2010 | 369 | 0.090 |
Why?
|
| Hemiplegia | 1 | 2007 | 10 | 0.080 |
Why?
|
| Arm | 1 | 2007 | 30 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2011 | 319 | 0.080 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 32 | 0.080 |
Why?
|
| Hand | 1 | 2007 | 59 | 0.080 |
Why?
|
| Coffee | 2 | 2003 | 10 | 0.080 |
Why?
|
| Contrast Media | 2 | 2009 | 127 | 0.080 |
Why?
|
| Rest | 2 | 2017 | 50 | 0.080 |
Why?
|
| Time Perception | 1 | 2006 | 4 | 0.080 |
Why?
|
| Judgment | 1 | 2006 | 13 | 0.080 |
Why?
|
| Cotinine | 2 | 2017 | 49 | 0.080 |
Why?
|
| Pitch Discrimination | 1 | 2005 | 1 | 0.080 |
Why?
|
| Diffusion | 2 | 2002 | 12 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2006 | 42 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 523 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1032 | 0.070 |
Why?
|
| Discrimination Learning | 1 | 2005 | 20 | 0.070 |
Why?
|
| Single-Blind Method | 3 | 2017 | 169 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2019 | 275 | 0.070 |
Why?
|
| Muscle Strength | 2 | 2017 | 129 | 0.070 |
Why?
|
| Time Factors | 3 | 2006 | 2000 | 0.070 |
Why?
|
| Adolescent | 5 | 2011 | 3127 | 0.070 |
Why?
|
| Probability | 2 | 2017 | 148 | 0.070 |
Why?
|
| Blood Volume | 1 | 2004 | 14 | 0.070 |
Why?
|
| Evoked Potentials | 1 | 2003 | 16 | 0.070 |
Why?
|
| Sound Localization | 1 | 2003 | 6 | 0.060 |
Why?
|
| Myopia | 1 | 2003 | 5 | 0.060 |
Why?
|
| Arousal | 1 | 2003 | 19 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2004 | 65 | 0.060 |
Why?
|
| Stroke | 1 | 2009 | 552 | 0.060 |
Why?
|
| Brain Edema | 1 | 2003 | 16 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2005 | 917 | 0.060 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2003 | 23 | 0.060 |
Why?
|
| Cluster Analysis | 2 | 2014 | 123 | 0.060 |
Why?
|
| Psychophysiology | 1 | 2002 | 2 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 141 | 0.060 |
Why?
|
| Age Factors | 3 | 2014 | 1123 | 0.060 |
Why?
|
| Gadolinium DTPA | 1 | 2002 | 13 | 0.060 |
Why?
|
| Dominance, Cerebral | 1 | 2002 | 11 | 0.060 |
Why?
|
| Hearing | 1 | 2002 | 11 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2002 | 13 | 0.060 |
Why?
|
| Language | 1 | 2002 | 47 | 0.060 |
Why?
|
| Research Design | 1 | 2004 | 277 | 0.060 |
Why?
|
| Acute Disease | 1 | 2002 | 244 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 581 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2011 | 62 | 0.050 |
Why?
|
| Pain Threshold | 2 | 2011 | 94 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2019 | 26 | 0.050 |
Why?
|
| Pain Measurement | 2 | 2011 | 365 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2009 | 105 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2088 | 0.040 |
Why?
|
| Child | 3 | 2011 | 2007 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 2010 | 83 | 0.040 |
Why?
|
| Acetylcholinesterase | 1 | 2017 | 19 | 0.040 |
Why?
|
| Butyrylcholinesterase | 1 | 2017 | 18 | 0.040 |
Why?
|
| Sensory Thresholds | 2 | 2009 | 27 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2018 | 90 | 0.040 |
Why?
|
| Physical Endurance | 1 | 2017 | 37 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2016 | 3027 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 1662 | 0.040 |
Why?
|
| ROC Curve | 1 | 2016 | 152 | 0.040 |
Why?
|
| Cholinesterases | 1 | 2016 | 13 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2017 | 158 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2016 | 88 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2018 | 207 | 0.040 |
Why?
|
| Information Theory | 1 | 2014 | 3 | 0.030 |
Why?
|
| Psychometrics | 1 | 2015 | 136 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2017 | 291 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 367 | 0.030 |
Why?
|
| Behavior | 1 | 2013 | 29 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 25 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 44 | 0.030 |
Why?
|
| Reward | 1 | 2014 | 61 | 0.030 |
Why?
|
| Infant | 2 | 2009 | 895 | 0.030 |
Why?
|
| Agriculture | 1 | 2016 | 265 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2009 | 1095 | 0.030 |
Why?
|
| Reference Values | 2 | 2003 | 232 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2017 | 865 | 0.030 |
Why?
|
| Drive | 1 | 2012 | 2 | 0.030 |
Why?
|
| Postprandial Period | 1 | 2012 | 10 | 0.030 |
Why?
|
| Taste | 1 | 2012 | 17 | 0.030 |
Why?
|
| Water | 1 | 2012 | 50 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 2016 | 375 | 0.030 |
Why?
|
| Behavior, Addictive | 1 | 2012 | 28 | 0.030 |
Why?
|
| Bone Density | 1 | 2013 | 198 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2011 | 19 | 0.030 |
Why?
|
| Psychoacoustics | 1 | 2011 | 2 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2012 | 61 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 2011 | 23 | 0.030 |
Why?
|
| Energy Intake | 1 | 2012 | 122 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 54 | 0.030 |
Why?
|
| Random Allocation | 1 | 2011 | 217 | 0.030 |
Why?
|
| North Carolina | 1 | 2016 | 1642 | 0.030 |
Why?
|
| Mental Processes | 1 | 2010 | 17 | 0.030 |
Why?
|
| Hyperalgesia | 1 | 2011 | 85 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2012 | 164 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2011 | 328 | 0.020 |
Why?
|
| Saliva | 1 | 2009 | 35 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 3527 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2009 | 12 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 174 | 0.020 |
Why?
|
| Arteries | 1 | 2009 | 59 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2009 | 74 | 0.020 |
Why?
|
| Animals | 2 | 2011 | 7456 | 0.020 |
Why?
|
| Motor Skills | 1 | 2007 | 11 | 0.020 |
Why?
|
| Movement | 1 | 2007 | 30 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 656 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2009 | 141 | 0.020 |
Why?
|
| Fingers | 1 | 2007 | 46 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 453 | 0.020 |
Why?
|
| Organ Size | 1 | 2007 | 212 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 184 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2006 | 24 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2007 | 213 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 54 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 374 | 0.020 |
Why?
|
| Cerebral Ventriculography | 1 | 2003 | 3 | 0.020 |
Why?
|
| Subarachnoid Space | 1 | 2003 | 5 | 0.020 |
Why?
|
| Intracranial Pressure | 1 | 2003 | 17 | 0.020 |
Why?
|
| Fixation, Ocular | 1 | 2002 | 5 | 0.020 |
Why?
|
| Linear Models | 1 | 2003 | 427 | 0.010 |
Why?
|
| Acetazolamide | 1 | 2002 | 1 | 0.010 |
Why?
|
| Anisotropy | 1 | 2002 | 10 | 0.010 |
Why?
|
| Cadaver | 1 | 2002 | 131 | 0.010 |
Why?
|